Pfizer Sees FY24 Adj. EPS, Revenues Below Market; Stock Down In Pre Market

Drug major Pfizer Inc. (PFE) on Wednesday said it expects higher adjusted earnings and revenues for fiscal 2024, but both below market estimates. In pre-market activity on the NYSE, the shares were losing around 7.

Related Keywords

Albert Bourla ,Thomson Reuters ,Pfizer Inc ,Pfizer ,Pfizer Chairman ,Chief Executive Officer ,Drug Major ,Fizer Outlook ,Seagen ,Below Market ,